Durability of Effect With Long-Term Droxidopa Treatment in Patients with Symptomatic Neurogenic Orthostatic Hypotension

被引：0
|
作者：
Isaacson, Stuart [3 ]
Lisk, Jerome [4 ]
Liang, Grace [2 ]
Rowse, Gerald [1 ]
机构：
[1] Lundbeck NA Ltd, Charlotte, NC USA
[2] Neurocrine Biosci Inc, San Diego, CA USA
[3] Parkinsons Dis & Movement Disorders Ctr Boca Rato, Boca Raton, FL USA
[4] Southern Calif Movement Disorder Specialists, Pasadena, CA USA
来源：
NEUROLOGY | 2016年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P5.128
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Droxidopa (Northera) for Neurogenic Orthostatic Hypotension
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2015, 57 (1471): : 92 - 93
  • [42] Long-term evaluation of 24 hour ambulatory blood pressure monitoring in patients with Parkinson's disease and symptomatic neurogenic orthostatic hypotension treated with droxidopa
    Brillman, S.
    Husain, S.
    Isaacson, S. H.
    MOVEMENT DISORDERS, 2015, 30 : S72 - S73
  • [43] Integrated Analysis of Droxidopa for the Treatment of Neurogenic Orthostatic Hypotension in Patients with Parkinson Disease
    Hauser, Robert A.
    Biaggioni, Italo
    Hewitt, L. Arthur
    Vernino, Steven
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2018, 5 (06): : 627 - 634
  • [44] A Mixed Treatment Comparison of Droxidopa and Midodrine for the Treatment of Neurogenic Orthostatic Hypotension
    Chen, J. J.
    Han, Y.
    Tang, J.
    Dashtipour, K.
    MOVEMENT DISORDERS, 2017, 32 (09) : E5 - E6
  • [45] A MIXED TREATMENT COMPARISON OF DROXIDOPA AND MIDODRINE FOR THE TREATMENT OF NEUROGENIC ORTHOSTATIC HYPOTENSION
    Joe, Y.
    Joe, W.
    Chen, J. J.
    VALUE IN HEALTH, 2017, 20 (05) : A189 - A189
  • [46] Integrated safety of droxidopa for neurogenic orthostatic hypotension
    Kaufmann, H.
    Hauser, R. A.
    Lisk, J. P.
    Szakacs, C. B. N.
    MOVEMENT DISORDERS, 2014, 29 : S563 - S564
  • [47] Integrated efficacy of droxidopa for neurogenic orthostatic hypotension
    Hauser, R. A.
    Isaacson, S.
    Kaufmann, H.
    Hewitt, L. A.
    MOVEMENT DISORDERS, 2014, 29 : S562 - S562
  • [48] Droxidopa for the Short-Term Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Parkinson's Disease (nOH306B)
    Hauser, Robert A.
    Isaacson, Stuart
    Lisk, Jerome P.
    Hewitt, L. Arthur
    Rowse, Gerry
    MOVEMENT DISORDERS, 2015, 30 (05) : 646 - 654
  • [49] Effects of Droxidopa Treatment for Neurogenic Orthostatic Hypotension in Patients Concomitantly on Dopa Decarboxylase Inhibitors
    Kymes, Steve
    Francois, Clement
    Sullivan, Christine
    McLeod, Kim
    Duhig, Amy
    Ogbonnaya, Augustina
    Quillen, Apryl
    Cannon, Joan
    Biaggioni, Italo
    Shibao, Cyndya A.
    Yue, Binglin
    Hauser, Robert
    NEUROLOGY, 2019, 92 (15)
  • [50] Effects of Droxidopa Treatment for Neurogenic Orthostatic Hypotension in Patients Concomitantly on Dopa Decarboxylase Inhibitors
    Kymes, Steven
    Francois, Clement
    Sullivan, Christine
    McLeod, Kim
    Duhig, Amy
    Ogbonnaya, Augustina
    Quillen, Apryl
    Cannon, Joan
    Biaggioni, Italo
    Shibao, Cyndya
    Yue, Binglin
    Hauser, Robert
    MOVEMENT DISORDERS, 2018, 33 : S69 - S69
12345